FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2586383721> ?p ?o ?g. }

• W2586383721 endingPage "24901" @default.
• W2586383721 startingPage "24892" @default.
• W2586383721 abstract "// Xiaobing Wang 1, * , Zhaogang Yang 2, * , Haimei Tian 1 , Yanfen Li 1 , Mo Li 1 , Wenya Zhao 1 , Chao Zhang 1 , Teng Wang 1 , Jing Liu 1 , Aili Zhang 2 , Di Shen 3 , Cuining Zheng 3 , Jun Qi 3 , Dan Zhao 4 , Junfeng Shi 2, 5 , Liliang Jin 6 , Jianyu Rao 1 , Wei Zhang 1 1 Tumor Marker Research Center, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, PR China 2 NSF Nanoscale Science and Engineering Center (NSEC), The Ohio State University, Columbus, OH, USA 3 Laboratory of Clinical Biochemistry, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, PR China 4 Department of Gynecological Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, PR China 5 Department of Mechanical Engineering, The Ohio State University, Columbus, OH, USA 6 Department of Pathobiological Sciences, Louisiana State University, Baton Rouge, LA, USA * These authors have contributed equally to this work Correspondence to: Wei Zhang, email: zhangww1954@126.com Keywords: colorectal cancer, biomarker, screening, liver metastasis, prognosis Received: September 13, 2016     Accepted: January 06, 2017     Published: February 11, 2017 ABSTRACT Macrophage inhibitory cytokine 1 (MIC-1/GDF15) has been characterized as a candidate biomarker for colorectal cancer (CRC) recently. However, the role of serum MIC-1 in screening patients with early stage CRC and monitoring therapeutic response have not been well-established, particularly in the combination with CEA for the screening and the prejudgment of occurrence with liver metastasis. In this study, we performed a retrospective blinded evaluation of 987 serum samples from 473 individuals with CRC, 25 with adenomatous polyps, and 489 healthy individuals using ELISA or immunoassay. The sensitivity of serum MIC-1 was 43.8% and 38.5% for CRC diagnosis and early diagnosis, respectively, which were independent of and comparatively higher than for CEA (36.6% and 27.3%) at comparable specificity. Serum MIC-1 after surgery were significantly elevated at the time of tumor recurrence, and notable increase were observed in 100% patients with liver metastasis. Besides the TNM classification and differentiation grade, MIC-1 was an independent prognostic factor contributing to overall survival. We conclude that MIC-1 can act as a candidate complementary biomarker for screening early-stage CRC by combination with CEA, and furthermore, for the first time, identify a promising prognostic indicator for monitoring recurrence with liver metastasis, to support strategies towards personalized therapy." @default.
• W2586383721 created "2017-02-17" @default.
• W2586383721 creator A5005368388 @default.
• W2586383721 creator A5009363967 @default.
• W2586383721 creator A5012788495 @default.
• W2586383721 creator A5019226238 @default.
• W2586383721 creator A5019685555 @default.
• W2586383721 creator A5019699774 @default.
• W2586383721 creator A5028427087 @default.
• W2586383721 creator A5035282947 @default.
• W2586383721 creator A5040179504 @default.
• W2586383721 creator A5047490937 @default.
• W2586383721 creator A5047847539 @default.
• W2586383721 creator A5059525223 @default.
• W2586383721 creator A5063151866 @default.
• W2586383721 creator A5067919485 @default.
• W2586383721 creator A5071813677 @default.
• W2586383721 creator A5074639070 @default.
• W2586383721 creator A5090370578 @default.
• W2586383721 creator A5090797299 @default.
• W2586383721 date "2017-02-11" @default.
• W2586383721 modified "2023-10-16" @default.
• W2586383721 title "Circulating MIC-1/GDF15 is a complementary screening biomarker with CEA and correlates with liver metastasis and poor survival in colorectal cancer" @default.
• W2586383721 cites W1507985456 @default.
• W2586383721 cites W1966091545 @default.
• W2586383721 cites W1971880963 @default.
• W2586383721 cites W1981989535 @default.
• W2586383721 cites W1989426535 @default.
• W2586383721 cites W1989468717 @default.
• W2586383721 cites W1990360071 @default.
• W2586383721 cites W1991385417 @default.
• W2586383721 cites W2015571277 @default.
• W2586383721 cites W2021362203 @default.
• W2586383721 cites W2028923538 @default.
• W2586383721 cites W2041389244 @default.
• W2586383721 cites W2054637745 @default.
• W2586383721 cites W2061460086 @default.
• W2586383721 cites W2091720107 @default.
• W2586383721 cites W2109560931 @default.
• W2586383721 cites W2113000309 @default.
• W2586383721 cites W2129177370 @default.
• W2586383721 cites W2129218179 @default.
• W2586383721 cites W2141647862 @default.
• W2586383721 cites W2142240433 @default.
• W2586383721 cites W2144692208 @default.
• W2586383721 cites W2147579615 @default.
• W2586383721 cites W2148106468 @default.
• W2586383721 cites W2166811751 @default.
• W2586383721 cites W2235523093 @default.
• W2586383721 cites W2276626946 @default.
• W2586383721 cites W2288433605 @default.
• W2586383721 cites W2294838958 @default.
• W2586383721 cites W2300050735 @default.
• W2586383721 cites W2329589109 @default.
• W2586383721 cites W2462619809 @default.
• W2586383721 cites W2473149768 @default.
• W2586383721 cites W3016817568 @default.
• W2586383721 doi "https://doi.org/10.18632/oncotarget.15279" @default.
• W2586383721 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5421897" @default.
• W2586383721 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28206963" @default.
• W2586383721 hasPublicationYear "2017" @default.
• W2586383721 type Work @default.
• W2586383721 sameAs 2586383721 @default.
• W2586383721 citedByCount "34" @default.
• W2586383721 countsByYear W25863837212017 @default.
• W2586383721 countsByYear W25863837212018 @default.
• W2586383721 countsByYear W25863837212019 @default.
• W2586383721 countsByYear W25863837212020 @default.
• W2586383721 countsByYear W25863837212021 @default.
• W2586383721 countsByYear W25863837212022 @default.
• W2586383721 countsByYear W25863837212023 @default.
• W2586383721 crossrefType "journal-article" @default.
• W2586383721 hasAuthorship W2586383721A5005368388 @default.
• W2586383721 hasAuthorship W2586383721A5009363967 @default.
• W2586383721 hasAuthorship W2586383721A5012788495 @default.
• W2586383721 hasAuthorship W2586383721A5019226238 @default.
• W2586383721 hasAuthorship W2586383721A5019685555 @default.
• W2586383721 hasAuthorship W2586383721A5019699774 @default.
• W2586383721 hasAuthorship W2586383721A5028427087 @default.
• W2586383721 hasAuthorship W2586383721A5035282947 @default.
• W2586383721 hasAuthorship W2586383721A5040179504 @default.
• W2586383721 hasAuthorship W2586383721A5047490937 @default.
• W2586383721 hasAuthorship W2586383721A5047847539 @default.
• W2586383721 hasAuthorship W2586383721A5059525223 @default.
• W2586383721 hasAuthorship W2586383721A5063151866 @default.
• W2586383721 hasAuthorship W2586383721A5067919485 @default.
• W2586383721 hasAuthorship W2586383721A5071813677 @default.
• W2586383721 hasAuthorship W2586383721A5074639070 @default.
• W2586383721 hasAuthorship W2586383721A5090370578 @default.
• W2586383721 hasAuthorship W2586383721A5090797299 @default.
• W2586383721 hasBestOaLocation W25863837211 @default.
• W2586383721 hasConcept C121608353 @default.
• W2586383721 hasConcept C126322002 @default.
• W2586383721 hasConcept C143998085 @default.
• W2586383721 hasConcept C17744445 @default.
• W2586383721 hasConcept C185592680 @default.
• W2586383721 hasConcept C191935318 @default.
• W2586383721 hasConcept C199539241 @default.

• next